What is your approach to using newer atypical antipsychotics in the treatment of schizophrenia?

E.g., Latuda (lurasidone), Fanapt (iloperidone), Vraylar (cariprazine), Rexulti (brexpiprazole), Caplyta (lumateperone), or Saphris (asenapine), Lybalvi (olanzapine/samidorphan)

Are there specific patient factors or indications that would influence you to choose one of these newer antipsychotics? How effective are they in your personal experience?

Answer from: at Community Practice

Latuda - great for mood stabilization and bipolar depression. A lot of people like it for borderline personality disorder, but it’s not FDA-approved for that. In my experience, not that great for psychosis or mania, but it also doesn’t really cause weight gain or QTc prolongation. Out ...

Comments

at Rancho Cucamonga
Thank you for sharing.

Answer from: at Community Practice

Cost and affordability. Access to meds.

Comments

at Private Practice
When I teach students about medications, I go over...

Answer from: at Community Practice

While I do not treat many patients who have schizophrenia in my outpatient practice, I do treat a lot of patients who have bipolar disorder. I agree with Dr. @Delaney. I would add that Caplyta (lumateperone) is one of the most weight-neutral of the atypical agents I have used. I have seen weight gai...

Comments

at Private Practice
Dr. @Littman and Dr. @Delaney: Even with the more...

at South Broward Hospital District
I usually don’t, if it’s Latuda or Abi...

Please select the option that best describes you:

What is your approach to using newer atypical antipsychotics in the treatment of schizophrenia?

Related Questions